Aetion Vice President Shares Insight on What RWE Means for the Medical Device Industry

March 12, 2021

Christian Howell, Vice President and General Manager of Medical Devices and Diagnostics at Aetion, shared his thoughts on how RWE can bring positive changes to the medical device industry and impact patients’ lives. Howell remarks that one key benefit of RWE is the ability to respond to medical device issues immediately, rather than waiting for the full cycle of a clinical trial.

According to Howell, “Much like we’ve discovered in the biopharma product lifecycle, RWE is going to be increasingly impactful for medical devices. RWE can support and improve upon a range of processes: from determining which cohort of patients can benefit most from an intervention, to informing regulatory approvals and complementing data from randomized controlled trials, to supporting reimbursement efforts and expanding indications of use.” Read more here.

(Source: Aetion, 2/11/21)

Share This Story!